Why Choose Us
Advanced Equipment
Our company has advanced production equipment, complete product testing methods, and quality assurance systems, and currently holds ISO/SGS/FDA/GMP/HALA certificates.
Quality Control
Using high-quality materials and establishing a strict quality control system, assigning specific persons in charge of each part of production, from raw material procurement to assembly.
Professional Team
The researchers employed have 15 years of working experience in the plant extraction industry. A range of new products is released every month.
Competitive Price
The company may offer competitive pricing compared to their competitors, making them a more attractive option to budget-conscious customers.
Retatrutide (LY-3437943) is a developing drug for treating obesity and type 2 diabetes mellitus. This active compound activates receptor agonists in our bodies that help with blood sugar control and body weight loss management. Just like Ozempic or Wegovy (semaglutide), retatrutide is a glucagon-like peptide-1 (GLP-1) agonist. And in the same way as Mounjaro, this new drug also acts as another hormone called glucose-dependent insulinotropic polypeptide (GIP). Both hormones combined do wonders in promoting weight loss. But retatrutide takes the game one step further; this drug also acts as a third hormone: glucagon.
Benefits of Retatrutide Peptide
Enhanced cognitive function
Retatrutide peptide can improve memory and learning ability by increasing the production of brain-derived neurotrophic factor (BDNF) and enhancing synaptic plasticity.
Anti-depressant effects
Retatrutide peptide can alleviate depression by increasing the levels of serotonin and dopamine in the brain, which are associated with feelings of happiness and well-being.
Improved cardiovascular function
Retatrutide peptide can improve heart function by increasing blood flow to the heart and decreasing blood pressure.
Increased energy
Retatrutide peptide can boost energy levels by increasing the production of ATP, which is the primary source of energy for cells.
Anti-inflammatory effects
Retatrutide peptide can reduce inflammation in the body by regulating the immune response and reducing the production of inflammatory cytokines.
Improved skin health
Retatrutide peptide can improve skin health by increasing collagen production, which helps to reduce wrinkles and improve skin elasticity.
What are the Applications of Retatrutide Peptide
Neuroprotection
Retatrutide peptide has been shown to have neuroprotective effects, protecting neurons from damage caused by stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
Pain management
Studies have demonstrated that retatrutide peptide can reduce pain sensitivity in animal models, raising the possibility of its application in the management of chronic pain in humans.
Drug delivery
The TAT peptide sequence used in the retatrutide peptide has a cell-penetrating ability, which allows it to enter cells more easily. This makes it an attractive candidate for drug delivery systems, especially for drugs that have a low cellular uptake.
Cancer treatment
Research has suggested that retatrutide peptide can enhance immune responses against cancer cells by activating natural killer cells and T-cells, potentially making it a useful adjuvant therapy for cancer treatment.
Regenerative medicine
Retatrutide peptide has been shown to promote bone regeneration and wound healing in animal models, hinting at its possible use in regenerative medicine.
What is the composition of retatrutide?
Retatrutide, a triple agonist of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors, shows promise in obesity management albeit with concerns about delayed gastric emptying.
What makes retatrutide stand out from other drugs?
Retatrutide may still be in development, but the results from clinical trials show how promising this new drug is for weight management. Retatrutide comes to raise the bar of this type of weight loss medication by delivering a larger percentage of body weight loss.
While on the highest dose of Wegovy (the weight loss version of Ozempic), individuals lose up to 15% of body weight in about 68 weeks. Mounjaro came to enhance the game by promoting 22% of body weight loss in around 72 weeks. In Eli Lilly's latest clinical trials, retatrutide's highest dose helped patients lose 24,2% body weight in only 48 weeks. Not only retatrutide promotes more significant weight loss, but it also does it in an incredibly shorter period of time; it beats how long does Ozempic take to work.
Retatrutide vs. Other Weight Loss Drugs
When it comes to Retatrutide, the novel medication acts by targeting glucagon receptors, leading to superior weight loss. Specifically, the glucagon signals the liver to exert stored sugar, soon to be broken down by the bodyDespite the ongoing research, preliminary data from the phase 2 trial indicate that Retatrutide may surpass other weight-loss drugs introduced by Eli Lilly when treating obesity and related conditions.it is evident that Retatrutide is expected to precede its predecessors by facilitating people with obesity and other overweight-related conditions, shedding extra weight by up to 25%. an endocrinologist the phase 2 trial demonstrates that Retatrutide might be more potent for regulating hunger, quoted as "the most effective anti-obesity med to date."
How Retatrutide Works
1.Astric inhibitory polypeptide receptor (GIPR) agonist
As a GIP receptor agonist, retatrutide enhances appetite suppression and prevents fat accumulation, resulting in decreased energy intake and increased energy expenditure.
2.Glucagon-like peptide 1 receptor (GLP-1R) agonist
Retatrutide reduces body weight by improving blood sugar levels via enhanced insulin release from the pancreas and reduced release of glucagon (a hormone that increases blood sugar).
3.Glucagon receptor (GR) agonist
Retatrutide decreases glucagon release to improve blood sugar levels, decrease food intake, and increase energy expenditure which ultimately results in weight loss.
he use of retaglutide can provide the following benefits
Blood sugar control
Retatrutide can stimulate the secretion of insulin and lower blood sugar levels, thereby effectively controlling blood sugar levels in diabetic patients.
Weight loss
It can help people with diabetes lose weight by suppressing appetite and reducing food intake.
Cardiovascular protection
It can reduce blood pressure and blood lipids, has a certain protective effect on cardiovascular disease, and is conducive to the prevention of cardiovascular diseases.
Liver protection
It can reduce liver enzyme levels, protect the liver, and help prevent liver diseases.
Retatrutide is a new drug for obesity that is currently being developed by Eli Lilly. The initial dose of retatrutide is 0.5 mg, which is injected subcutaneously once weekly. The dose of the drug can be increased to 1 mg, 2 mg, or 4 mg after 4 weeks, depending on the patient's response. The maximum dose is 12 mg per week.
The initial dose of retatrutide is important because it helps to minimize the risk of side effects. If the patient tolerates the initial dose well, the dose can be increased gradually. However, if the patient experiences any serious side effects, the dose of the drug should be reduced or discontinued.
Coverage areas of Retarglutide
A phase 2 clinical trial of retatrutide (LY3437943) in the treatment of obesity. The primary end point was percentage change in weight from baseline to 24 weeks, which ranged from −7.2% to -~18% as the dose of retatrutide increased from 1 mg to 12 mg. The most frequent adverse events were gastrointestinal (nausea, diarrhea, vomiting).
he results for retatrutide in phase 2 for obesity (and diabetes) are mostly encouraging. Consistent with being a GLP-1 receptor agonist, heart rate was increased by up to 6.7 beats/min by retatrutide, which may be detrimental and offset some of the benefits of weight loss. Presumably, retatrutide is being developed as a challenger to the recently developed weight loss medicines; semaglutide and/or tirzepatide. Thus, comparator studies are needed between retatrutide and these drugs, but none are ongoing and, in my opinion, this lack is a major omission in the development of retatrutide.
Retatrutide Effectively Reduces Body Weight In Patients With Obesity
Study Rundown: Obesity is an increasingly prevalent chronic disease that can be difficult to effectively manage. It is associated with significant cardiovascular morbidity and mortality. In addition to lifestyle modifications and previous pharmacotherapies, glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide and tirzepatide have proven highly effective by targeting the underlying neuroendocrine pathophysiology of obesity. Retatrutide is a novel triple-agonist of GLP-1, glucose-dependent insulinotropic polypeptide (PIP), and glucagon receptors. This study was a phase two trial to assess the efficacy and safety of retatrutide among patients with obesity. Compared to placebo, the weekly retatrutide injections resulted in significant weight reductions through 48 weeks, with between 60-82% of patients achieving a 15% weight reduction depending on the dosage. These reductions were accompanied by other metabolic parameters. Retatrutide also had an acceptable safety profile, with most adverse events being gastrointestinal and dose-dependent. The study was mainly limited by its lack of racial diversity and a small proportion of overweight patients with obesity-related conditions. Nonetheless, these results demonstrated the potential of retatrutide in treating obesity and improving metabolic measures.
Xian Herben Biotech Co., LTD. was established in 2018, located in the ancient city of China - Xi'an. It is a comprehensive company integrating production, sales and service. Focus on healthcare and OEM processing, mainly exporting medicine and health raw materials, plant extracts, API & Intermedium and so on.
Our company has advanced production equipment, perfect product testing methods and quality assurance system, and existing ISO / SGS / FDA / GMP / HALA certificates. Have a professional R & D team, production team, sales team and after-sales service team. Since its establishment, it has played its own advantages, improved its sales network, and paid attention to the company's image, winning the praise of customers. Our products has been exported to Japan, the United States, Europe, India, Southeast Asia and other parts of the world. We always abide by the consistency of "quality first, integrity first", in the spirit of "innovation, enterprising", and will wholeheartedly provide our customers with high-quality products and enthusiastic services.
FAQ
Q: When will retatrutide be available?
Q: What is retatrutide and how does it work?
Q: What are the benefits of retatrutide?
Q: What are the side effects of the retatrutide trial?
Q: How does retatrutide work for weight loss?
Q: What are the best times to take peptides?
Q: How many times a day should you use peptides?
Q: Is retatrutide the same as Ozempic?
Q: What is the mechanism of action of retatrutide?
Q: What is the most successful weight loss pill?
Q: What hormones are in retatrutide?
Q: What is the chemical name for retatrutide?
Q: How is Retatrutide Peptide administered?
Q: Is Retatrutide Peptide safe?
Q: Are there any drug interactions with Retatrutide Peptide?
Q: Can Retatrutide Peptide be used by athletes?
Q: When will retatrutide be FDA approved?
Q: What were the results of the retatrutide trial?
Q: Is Retatrutide a cure for Alzheimer's disease?
Q: How long does it take for Retatrutide to work?
Hot Tags: Retatrutide 20mg, China Retatrutide 20mg manufacturers, suppliers, factory, , , ,
